CureVac N.V.CureVac N.V.CureVac N.V.

CureVac N.V.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪818.72 M‬USD
−1.32USD
‪−281.27 M‬USD
‪58.12 M‬USD
‪93.16 M‬
Beta (1Y)
0.99

About CureVac N.V.

CEO
Alexander Zehnder
Headquarters
Tübingen
Employees (FY)
‪1.17 K‬
Founded
2020
ISIN
NL0015436031
FIGI
BBG00W9LXXJ4
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CVAC is 3.72 USD — it has increased by 1.92% in the past 24 hours. Watch CureVac N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CureVac N.V. stocks are traded under the ticker CVAC.
CVAC stock has risen by 13.76% compared to the previous week, the month change is a 7.20% rise, over the last year CureVac N.V. has showed a 62.00% decrease.
We've gathered analysts' opinions on CureVac N.V. future price: according to them, CVAC price has a max estimate of 18.01 USD and a min estimate of 2.59 USD. Watch CVAC chart and read a more detailed CureVac N.V. stock forecast: see what analysts think of CureVac N.V. and suggest that you do with its stocks.
CVAC reached its all-time high on Dec 9, 2020 with the price of 151.80 USD, and its all-time low was 2.22 USD and was reached on Apr 25, 2024. View more price dynamics on CVAC chart.
See other stocks reaching their highest and lowest prices.
CVAC stock is 6.96% volatile and has beta coefficient of 0.99. Track CureVac N.V. stock price on the chart and check out the list of the most volatile stocks — is CureVac N.V. there?
Today CureVac N.V. has the market capitalization of ‪818.72 M‬, it has increased by 4.15% over the last week.
Yes, you can track CureVac N.V. financials in yearly and quarterly reports right on TradingView.
CureVac N.V. is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.
CVAC earnings for the last quarter are −0.33 USD per share, whereas the estimation was −0.29 USD resulting in a −15.52% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about CureVac N.V. earnings.
CureVac N.V. revenue for the last quarter amounts to ‪13.38 M‬ USD, despite the estimated figure of ‪11.41 M‬ USD. In the next quarter, revenue is expected to reach ‪5.83 M‬ USD.
CVAC net income for the last quarter is ‪−76.57 M‬ USD, while the quarter before that showed ‪−93.19 M‬ USD of net income which accounts for 17.83% change. Track more CureVac N.V. financial stats to get the full picture.
No, CVAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 18, 2024, the company has ‪1.17 K‬ employees. See our rating of the largest employees — is CureVac N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CureVac N.V. EBITDA is ‪−293.65 M‬ USD, and current EBITDA margin is −473.93%. See more stats in CureVac N.V. financial statements.
Like other stocks, CVAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CureVac N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CureVac N.V. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CureVac N.V. stock shows the sell signal. See more of CureVac N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.